Mount Desert Island Biological Laboratory’s (MDI) comparative toxicogenomics database (CTD) is a valuable, manually curated resource, which advances understanding the effects of environmental chemicals on human health. Biomax
The extensive multi-national patent portfolio covers Canica’s clinical and surgical system and method for moving and stretching skin and muscle. John Pratt, who led the intellectual property team
Most recently Dr Johnson was senior vice president of R&D at Nektar Therapeutics. Prior to Nektar, Dr Johnson was chief development officer for Control Delivery Systems. Dr Johnston
The Phase I trial was a randomized, double-blind, ascending multiple-dose study in which all dose levels were well tolerated over 14 days and no dose limiting toxicities were
The JAK3 kinase is being evaluated for the treatment of immunological and inflammatory diseases. The JAK3 is selectively expressed in certain hematopoietic cells and is involved in T-cell
This patent, which allows exclusively through 2018, covers compositions of fusion proteins comprised of a human papillomavirus (HPV) antigen fused to a heat shock protein, as well as
The investigational new drug (IND) application contains a physical, chemical and structural analysis of safflower-produced insulin to a reference standard, results from 28-day sub-chronic toxicology studies in two
This double-blind, placebo-controlled, single-ascending dose (SAD) trial will determine the safety, tolerance and pharmacokinetics of a single intravenous (IV) administration of NU206, in approximately 48 healthy male volunteers.
Under the terms of the agreement, Agilent will obtain from Roche a non-exclusive license to use, develop and sell products based on melting curve analysis. The melting curve
DoctorDirectory’s IncreaseRx utilizes web-based educational and promotional tactics to reach tens of thousands of interested prescribers with targeted sales and marketing messages. Essentially, IncreaseRx performs as a virtual
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.